compound, pharmaceutical formulation, method for treating or preventing lipid disorders (dyslipidemia), use of a compound, method for treating or preventing type 2 diabetes, pharmaceutical composition, process for preparing a compound, and, prodrug of a compound

摘要

"COMPOUND, PHARMACEUTICAL FORMULATION, METHOD FOR TREATING OR AVOIDING LIPID DISORDERS (DYSLIPIDEMIA), USE OF A COMPOUND, METHOD FOR TREATING OR AVOIDING DIABETES TYPE 2, COMPARISON OF PHARMACEUTICAL, PROPRODUCE OF A COMPOUND, PRODUCT . A compound of Formula (1) wherein T represents O, S or NR and where R represents an H, a C 1 -C 6 alkyl group or a C 1 -C 6 phenyl group alkyl and pharmaceutically acceptable salts thereof, processes for preparing such compounds, their utility in the treatment of clinical conditions, including lipid disorders (dyslipidemias), whether or not associated with insulin resistance, methods for their therapeutic use and pharmaceutical compositions containing them.